The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein

DJ Slamon, 1989, Science, 244, 707, 10.1126/science.2470152

K Sakai, 1986, J Natl Cancer Inst, 77, 1047

T Takehana, 2002, Int J Cancer, 98, 833, 10.1002/ijc.10257

PM Ravdin, 1995, Gene, 159, 19, 10.1016/0378-1119(94)00866-Q

H Allgayer, 2000, J Clin Oncol, 18, 2201, 10.1200/JCO.2000.18.11.2201

M Nakajima, 1999, Cancer, 85, 1894, 10.1002/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-J

T Mizutani, 1993, Cancer, 72, 2083, 10.1002/1097-0142(19931001)72:7<2083::AID-CNCR2820720705>3.0.CO;2-1

CL Vogel, 2002, J Clin Oncol, 20, 719, 10.1200/JCO.2002.20.3.719

M Tanner, 2005, Ann Oncol, 16, 273, 10.1093/annonc/mdi064

C Louvet, 2002, J Clin Oncol, 20, 4543, 10.1200/JCO.2002.02.021

TR Evans, 2002, Ann Oncol, 13, 1469, 10.1093/annonc/mdf243

DJ Slamon, 2001, N Engl J Med, 344, 783, 10.1056/NEJM200103153441101

HJ Burstein, 2001, J Clin Oncol, 19, 2722, 10.1200/JCO.2001.19.10.2722

A Webb, 1997, J Clin Oncol, 15, 1, 10.1200/JCO.1997.15.1.261